Canopy Partners
GILD icon

Canopy Partners’s Gilead Sciences GILD Stock Holding History

Canopy Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$533K Buy
3,579
+197
+6% +$27.6K 0.15% 122
2026
Q2 		$427K Sell
3,382
-375
-10% -$49.4K 0.13% 142
2026
Q1 		$524K Buy
3,757
+302
+9% +$42.3K 0.18% 106
2025
Q4 		$424K Buy
3,455
+177
+5% +$21.5K 0.14% 123
2025
Q3 		$364K Sell
3,278
-225
-6% -$25.6K 0.12% 140
2025
Q2 		$388K Hold
3,503
– – 0.14% 120
2025
Q1 		$393K Sell
3,503
-920
-21% -$94.9K 0.15% 116
2024
Q4 		$409K Buy
4,423
+43
+1% +$3.87K 0.16% 112
2024
Q3 		$367K Sell
4,380
-115
-3% -$8.78K 0.16% 122
2024
Q2 		$308K Buy
4,495
+435
+11% +$29K 0.14% 130
2024
Q1 		$297K Buy
4,060
+393
+11% +$30.2K 0.15% 132
2023
Q4 		$297K Buy
+3,667
New +$285K 0.18% 111

Other funds holding GILD

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Canopy Partners's GILD Position: Q3 2026 in Review

Canopy Partners increased its Gilead Sciences (GILD) stake by 5.8% in Q3 2026, buying an estimated $27.6K and bringing the position to 3,579 shares worth $533K. The position accounts for 0.15% of the portfolio, ranked #122.

Canopy Partners first reported a position in GILD in Q4 2023 and has held it in 12 quarters since. 1,998 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Canopy Partners held 3,579 shares of Gilead Sciences worth $533K as of Q3 2026.
  • Canopy Partners bought 197 Gilead Sciences shares in Q3 2026, an estimated $27.6K.
  • Gilead Sciences made up 0.15% of Canopy Partners's portfolio in Q3 2026, its #122 holding.
  • Canopy Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 12 quarters since.
  • 1,998 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Canopy Partners's 13F filing for Q3 2026, filed 28 Oct 2026.